Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

被引：0
|
作者：
Jamie Carter
Zhen Li
Hillary Chen
Melissa Greiner
Christopher Bush
Debanjan Bhattacharya
Stephanie Poley
Nidhi Sachdeva
Jane Carolyn Crowder
Jacob Feigal
机构：
[1] Lincoln Community Health Center,Department of Population Health Sciences
[2] Duke University School of Medicine,Department of Psychiatry and Behavioral Sciences
[3] Duke University School of Medicine,Department of Medicine
[4] Duke University School of Medicine,undefined
来源：
Addiction Science & Clinical Practice | / 17卷
关键词：
Opioid use disorder; Medication for opioid use disorder; Buprenorphine; Harm reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study
    Carter, Jamie
    Li, Zhen
    Chen, Hillary
    Greiner, Melissa
    Bush, Christopher
    Bhattacharya, Debanjan
    Poley, Stephanie
    Sachdeva, Nidhi
    Crowder, Jane Carolyn
    Feigal, Jacob
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [2] Nine-year substance use treatment outcomes with buprenorphine for opioid use disorder in a federally qualified health center
    Haddad, Marwan
    Coman, Emil
    Bifulco, Lauren
    DRUG AND ALCOHOL DEPENDENCE, 2024, 257
  • [3] Integration of a Community Opioid Treatment Program Into a Federally Qualified Health Center
    Neeb, Christine
    McQuade, Brianna M.
    Lesondak, Linda
    Madrid, Samantha
    Schlaeger, Judith M.
    Watson, Dennis P.
    Karnik, Niranjan
    Huerta, Noami
    Bhatia, Simar
    Fleurimont, Judes
    Li, Nicole
    Hammerdahl, Elsa
    Pesantez, Ricky
    Gastala, Nicole
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (06) : 663 - 669
  • [4] Virtual Music Therapy for Substance Use Disorders in a Federally Qualified Health Center
    Schoonover, Julie
    Rossetti, Andrew
    Jacobs, Ariel
    Rubin, Susan E.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2023, 36 (06) : 1043 - 1049
  • [5] Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
    Larochelle, Marc R.
    Bernson, Dana
    Land, Thomas
    Stopka, Thomas J.
    Wang, Na
    Xuan, Ziming
    Bagley, Sarah M.
    Liebschutz, Jane M.
    Walley, Alexander Y.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (03) : 137 - +
  • [6] Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study
    Bhatraju, Elenore P.
    Klein, Jared W.
    Hall, Allana N.
    Chen, David R.
    Iles-Shih, Matthew
    Tsui, Judith, I
    Merrill, Joseph O.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (04) : 461 - 465
  • [7] Initiation of medication for opioid use disorder across a health system: A retrospective analysis of patient characteristics and inpatient outcomes
    O'Rourke, Brian P.
    Hogan, Tory H.
    Teater, Julie
    Fried, Martin
    Williams, Margaret
    Miller, Alison
    Clark, Aaron D.
    Huynh, Phuong
    Kauffman, Emily
    Hefner, Jennifer L.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2022, 5
  • [8] Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intake
    Oles, William
    Alexander, Marcus
    Kumar, Navin
    Howell, Benjamin
    O'Connor, Patrick G.
    Madden, Lynn M.
    Barry, Declan T.
    BMC PSYCHIATRY, 2022, 22 (01)
  • [9] Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study
    Lira, Marlene C. C.
    Jimes, Cynthia
    Coffey, M. Justin
    TELEMEDICINE AND E-HEALTH, 2023, 29 (12) : 1890 - 1896
  • [10] Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder
    Hughto, Jaclyn M. W.
    Moyo, Patience
    Green, Traci C.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : E414 - E416
12345